Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

How BioPharma Credit (LSE:BPCR) Generates Income From Life-Sciences Lending

The model has been busy in 2026. Since March the trust has announced new loans to Zenas BioPharma, Mineralys Therapeutics, Idorsia, Kestra Medical and the ARCHIMED-backedAcquisitionof Esperion, while also closing out its long-running LumiraDx exposure. That flurry of deals matters because the company ended …

Divya Sood | 25 September 2026

Why Did ImmuPharma Plc LSE:IMC Fall 4.40% Amid a softer tone across London-listed biotech shares?

ImmuPharma Plc — LSE:IMC closed 4.40% lower on24 September 2026, with the shares at 3.81p after a fall of 0.18p on the day.

Ankur Sharma | 24 September 2026

Why Did Poolbeg Pharma Plc LSE:POLB Fall 4.56% Amid a softer tone across London-listed biotech shares?

Poolbeg Pharma Plc — LSE:POLB closed 4.56% lower on24 September 2026, with the shares at 8.64p after a fall of 0.41p on the day.

Ankur Sharma | 24 September 2026

Why Did RUA Life Sciences Plc LSE:RUA Fall 0.36% Amid a softer tone across London-listed medical polymer shares?

RUA Life Sciences Plc — LSE:RUA closed 0.36% lower on24 September 2026, with the shares at 27.90p after a fall of 0.10p on the day.

Ankur Sharma | 24 September 2026

Why Was AOTI, Inc. LSE:AOTI Unchanged Amid mixed trading across London-listed medical device shares?

AOTI, Inc. — LSE:AOTI closed unchanged on24 September 2026, with the shares at 130.00p and no change on the day.

Ankur Sharma | 24 September 2026

Why Did Genedrive Plc LSE:GDR Rise 2.07% Amid a firmer tone across London-listed molecular diagnostics shares?

Genedrive Plc — LSE:GDR closed 2.07% higher on24 September 2026, with the shares at 1.22p after a gain of 0.02p on the day.

Ankur Sharma | 24 September 2026

Why ValiRx (VAL) Is Seeing Fresh Biotech Volatility on AIM Against the FTSE AIM All-Share Backdrop

ValiRx (LSE:VAL) is a small life sciences company that selects early-stage drug candidates, mainly in oncology, and aims to develop them to the point where they can be licensed or funded through subsidiaries. Its shares were among the most volatile on the UK market …

Ankur Sharma | 24 September 2026

Why Provexis (PXS) Is Turning Heads Against the FTSE AIM All-Share

Provexis plc (LSE:PXS) was among the most volatile UK stocks on 23 September 2026. The Reading-based company develops and sells Fruitflow, a tomato extract that it describes as scientifically proven to inhibit platelet aggregation, for use in dietary supplements and functional foods.

Ankur Sharma | 24 September 2026

Why Proteome Sciences (PRM) Is Suddenly a Volatility Magnet Against the FTSE AIM All-Share

Proteome Sciences plc (LSE:PRM), the AIM-quoted protein biomarker and mass-spectrometry specialist, was named among the most volatile UK stocks on 23 September 2026. The listing followed a busy fortnight: on 15 September the company confirmed a further GCLP-grade chemoproteomics contract, and on 16 September …

Ankur Sharma | 24 September 2026

Why Has ImmuPharma (LSE:IMM) Fallen 17.04% as Investors Reassess P140 and Kapiglucagon?

ImmuPharma plc —LSE:IMMis in focus on September 24, 2026, after its shares fell17.04%in the trading data provided.

Ankur Sharma | 24 September 2026
Support

Hi! How can we help you today?

Loading…